Image pharmaphorum Editor Sales & Marketing The evolving role of social media in healthcare In recent years, social media has evolved into an essential part of pharma operations, for better or worse. R&D Competition is on the horizon for costly narcolepsy treatmen... People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. Views & Analysis Bringing the Benefits of eCOA BYOD Strategies to Clinical St... Over the past few years, many clinical study administrators wanted to use the bring your own device (BYOD) model within their eCOA, but they were typically constrained by regulatory require Digital How cost-effective are infectious disease vaccines? Cost-effectiveness modelling is a powerful tool in understanding the value health interventions can bring to populations. Load more results
Sales & Marketing The evolving role of social media in healthcare In recent years, social media has evolved into an essential part of pharma operations, for better or worse.
R&D Competition is on the horizon for costly narcolepsy treatmen... People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment.
Views & Analysis Bringing the Benefits of eCOA BYOD Strategies to Clinical St... Over the past few years, many clinical study administrators wanted to use the bring your own device (BYOD) model within their eCOA, but they were typically constrained by regulatory require
Digital How cost-effective are infectious disease vaccines? Cost-effectiveness modelling is a powerful tool in understanding the value health interventions can bring to populations.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
